Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model.

Uwe Pleyer, Jessica K. Milani, Andres J Dukes, Joseph Chou, Sabine Lutz, Dieter Rückert, Heinz‐Jürgen Thiel, Bartly J. Mondino

PubMed · 1995 · 57 citations · 6 references

Abstract

The results suggest that treatment with topically applied LIP-anti-CD4 mAb prolongs graft survival in orthotopic corneal grafts in a rat model. The beneficial effect of LIP-anti-CD4 mAb, probably due to enhanced intraocular delivery, was achieved by using relatively low doses of mAb.

References

6